Lupulin

(redirected from Humulin)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to Humulin: Humulin R, Humulin N

Lupulin

 

the commercial name for the glandules on the glumes of the fruit system (cones) and perianth of female hop blossoms (Humulus lupulus); also, the secretion from these glandules.

Solidified lupulin is a brownish yellow, sticky, coarse-grained powder containing essential oil, bitters, the alkaloid humulene, humulotannic acid, valerianic acid, gum, resin, wax, and a yellow pigment. Lupulin is used in brewing to give beer a pleasant, slightly bitter flavor, but it can also be toxic. A dose of 1-2 g may be mildly poisonous.

Mentioned in ?
References in periodicals archive ?
Cialis (tadalafil, Lilly) Cymbalta (duloxetine hydrochloride, Lilly) Effient (prasugrel, Lilly) Erbitux (cetuximab, ImClone Systems, Lilly) Evista (raloxifene hydrochloride, Lilly) Forteo (teriparatide of recombinant DNA origin injection, Lilly) Humalog (insulin lispro injection of recombinant DNA origin, Lilly) Humulin (human insulin of recombinant DNA origin, Lilly) Strattera (atomoxetine hydrochloride, Lilly) Tradjenta (linagliptin, Boehringer Ingelheim) Xigris (drotrecogin alfa (activated), Lilly) Zyprexa (olanzapine, Lilly)
There were 9,758 Zantac observations, 2,681 Humulin observations, 3,437 Mevacor observations, and 1,860 Dilantin observations.
sales of Humulin have been negatively impacted by the
Worldwide Humulin sales increased 5 percent in the fourth quarter of
Top 9 Insulin Brands (Novomix, Novorapid, Levemir, Degludec, Degludecplus, Humalog, Humulin, Apidra, Lantus) data of Past, Present and Future Market
According to a recent FundWeb article, this year marks the 30th anniversary of the "first biotechnology drug approved for human medical use," known as Humulin, "a genetically engineered version of natural human insulin for the treatment of diabetes.
Worldwide Humulin sales increased 7 percent in the second quarter of
Such biologics include Cerezyme (alglucerase), Humulin (human insulin), Intron A (interferon alpha-2b), Avonex (interferon beta-1a), Humatrope (somatropin), Epogen (epoetin alfa) and Neupogen (filgrastim).
Products such as Cymbalta, Humalog, Humulin, Forteo, Alimta, Cialis and our animal health portfolio all demonstrated solid growth in the quarter, as did key regions including Japan and the emerging markets.
In addition, study results also showed a significant reduction in postprandial blood glucose levels following administration of a standardized test meal and less hypoglycemia compared to Humulin R alone.
Additional results from this study for Humulin R alone and in combination with PH20 have been accepted for presentation at the European Association for the Study of Diabetes (EASD) meeting in Vienna on October 1, 2009.
This Phase 2 study investigated the pharmacokinetics (PK) and glucodynamics (GD) of Humalog and Humulin R with and without Halozyme's PH20 enzyme in 21 type 1 diabetic patients.